Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
SOLV logo

Solventum Secures $4 Billion Via Divestiture To Fuel Independence

SOLV10-KFiling Date: 2/27/2026
Solventum Corporation
Description

What this story covers

Solventum’s 2025 10-K highlights its transition from 3M, reporting $8.3 billion in sales. Despite $5 billion in debt and supply dependencies, the company is leveraging a $4 billion divestiture to focus on core MedSurg and AI-driven healthcare growth.

Story snapshot

CompanySolventum Corporation
TickerSOLV
VariantStandard detailed
Duration11:42
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001964738-26-000007
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in